Mirum Pharmaceuticals’ $80 Million Common Stock Offering

Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering.Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now